Prestige Consumer Healthcare Finalizes Breathe Right Acquisition
Summary
Prestige Consumer Healthcare Inc. has completed its acquisition of the Breathe Right® brand. This finalizes the strategic agreement that was initially announced via an 8-K filing on March 20, 2026. The completion integrates a well-known over-the-counter product into Prestige's portfolio, executing on its stated growth strategy.
At the time of this announcement, PBH was trading at $47.87 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $42.62 to $85.57. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.